MRD in CR patients in each randomization arm after completion of the randomly allocated treatment
| . | Nonrandomized patients, no. . | CR group (N = 105) . | Non-CR group (N = 94) . | ||
|---|---|---|---|---|---|
| Observation, no. . | ASCT, no. . | ASCT, no. . | FC, no. . | ||
| CR patients | 3 | 49 | 50 | 27 | 26 |
| Not done | 3 | 29 | 18 | 2 | 10 |
| Positive MRD | 17 (85%) | 20 (62.5%) | 17 (68%) | 9 (53.3%) | |
| Negative MRD | 3 (15%) | 12 (37.5%) | 8 (32%) | 7 (46.7%) | |
| . | Nonrandomized patients, no. . | CR group (N = 105) . | Non-CR group (N = 94) . | ||
|---|---|---|---|---|---|
| Observation, no. . | ASCT, no. . | ASCT, no. . | FC, no. . | ||
| CR patients | 3 | 49 | 50 | 27 | 26 |
| Not done | 3 | 29 | 18 | 2 | 10 |
| Positive MRD | 17 (85%) | 20 (62.5%) | 17 (68%) | 9 (53.3%) | |
| Negative MRD | 3 (15%) | 12 (37.5%) | 8 (32%) | 7 (46.7%) | |